In 2023, Barbara Weber, M.D. earned $1.04M in total compensation at Tango Therapeutics, including $626.00K salary and $396.58K bonus. Most recently sold 9,138 shares in Feb 2024. Currently holds stock worth $16.66M. 8+ years at the helm of Tango Therapeutics.
Compensation History
Annual executive compensation data for Barbara Weber, M.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.04M
Salary
$626.00K
Bonus
$396.58K
Other
$17.24K
Salary
$626.00KBoard Justification
The compensation philosophy is designed to attract and retain top talent while aligning executive compensation with company performance and shareholder interests.
Bonus
$396.58KBoard Justification
The bonus for 2023 was based on achieving corporate performance metrics, resulting in a payout of 115% of the target bonus.
Other Compensation
$17.24KBoard Justification
Other compensation includes $13,200 of matching contributions under the 401(k) plan, $2,100 of commuter benefits, and $1,300 for phone services paid by the company.
Restricted Stock
Board Justification
No stock was reported as vested in 2023; only stock grants and options are included in the total compensation calculations.
Performance Metrics
Performance metrics for 2023 included research and development advances, operational and strategic metrics, and individual contributions.
Barbara Weber, M.D.
CEO of Tango Therapeutics
Education
B.S. in Chemistry and an M.D. from the University of Washington
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
CEO of Tango Therapeutics for
8 years 9 months (Mar 2017 - Present)
Previous Experience
Senior Vice President, Oncology Translational Medicine, Novartis; Vice President, Oncology, GSK; Professor, Medicine and Genetics, University of Pennsylvania
Holdings
Track Barbara Weber, M.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$116.28K
$116.28K
9,138 TNGX shares
What if they kept their stock?
If Barbara Weber, M.D. didn't sell their stock, today they would have:
Extra TNGX9,138 shares worth $88.00K.
This is -24.32% and $28.28K less than what they got when they sold the stock.
Insider Trading
Barbara Weber, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$115.06K
TNGX at $12.59/share
Feb 6, 2024
Sale
87,168 shares
TNGX
Feb 1, 2024
Received
89,545 shares
TNGX
Mar 1, 2023
Received
Rivals
Compare Barbara Weber, M.D. with competitor CEOs and industry peers.